Sign In
Buy ACT
$40.57
-0.580 (-1.41%)
At Close: Jun 03, 2026
Insights into the Worldwide Antidepressants Industry to 2030 - Identify Growth Segments for Investment - ResearchAndMarkets.com
05:04pm, Monday, 20'th Apr 2020
The "Antidepressants Global Market Report 2020-30: COVID 19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering.
AbbVie Analyst Upgrades Stock To Outperform, Looks Forward To 2021
04:50pm, Monday, 20'th Apr 2020
AbbVie Inc (NYSE: ABBV) shares already discount much of the risk emanating from the COVID-19 crisis, according to an analyst at RBC Capital Markets.The AbbVie Analyst Randall Stanicky upgraded AbbVie
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
02:20pm, Monday, 20'th Apr 2020
Ap19FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT.
MILLENNIUM PARTNERS, L.P. UK Regulatory Announcement: Form 8.3 - Allergan plc
02:15pm, Monday, 20'th Apr 2020
Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH IN
BRIEF-Abbvie Announces Extension Of Expiration Date For Exchange Offers For Allergan Notes
01:00pm, Monday, 20'th Apr 2020
Abbvie Inc:
AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes
12:00pm, Monday, 20'th Apr 2020
AbbVie Inc. (NYSE:ABBV) ("AbbVie") announced today the extension of the expiration date of the offers to exchange (each, an "Exchange Offer" and, collectively, the "Exchange Offers") any and all outst
Knight Announces the Re-Launch of Trelstar in Canada
11:30am, Monday, 20'th Apr 2020
Knight licensed the exclusive rights to commercialize Trelstar® in Canada from Debiopharm, a Swiss-based, global biopharmaceutical company. “We are excited to re-launch Trelstar®,” said Jonatha
Alembic Pharma share price up over 3 after USFDA tentatively approves conjunctivitis-related drug
06:09am, Monday, 20'th Apr 2020
The company has total 120 ANDA approvals (107 final approvals and 13 tentative approvals) from USFDA.
Farmers & Merchants Investments Inc. Reduces Position in Allergan plc (NYSE:AGN)
12:32pm, Sunday, 19'th Apr 2020
Farmers & Merchants Investments Inc. cut its holdings in shares of Allergan plc (NYSE:AGN) by 0.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securiti
CENTRAL TRUST Co Sells 524 Shares of Allergan plc (NYSE:AGN)
09:52am, Sunday, 19'th Apr 2020
CENTRAL TRUST Co lessened its holdings in shares of Allergan plc (NYSE:AGN) by 6.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The i
Nwam LLC Sells 1,680 Shares of Allergan plc (NYSE:AGN)
10:10am, Saturday, 18'th Apr 2020
Nwam LLC cut its position in Allergan plc (NYSE:AGN) by 36.4% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,932 shares of the comp
10 of the Best Blue-Chip Stocks to Buy for 2019
09:49pm, Friday, 17'th Apr 2020
The best blue-chip stocks for 2020. When investors think of blue-chip stocks, they think of tried and true, large companies with entrenched businesses. They think of robust cash flows, healthy financi
2020 Biosimilars Market Insights with a Review of 2015-2019 - ResearchAndMarkets.com
04:46pm, Friday, 17'th Apr 2020
The "Biosimilars Market Global Report 2020-30" report has been added to ResearchAndMarkets.com's offering.
